|
SYDNEY and NEW YORK, April 8, 2026 /PRNewswire/ -- Lumonus, the company behind Lumonus AI, a platform for radiation oncology clinical workflow and automated treatment planning, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK), one of the world's premier cancer centers and a leader in radiation therapy treatment planning research.
Through this relationship, Lumonus will license and co-develop MSK's ECHO mathematical optimization engine into the Lumonus platform and will invest in joint research focused on advancing automated radiation therapy treatment planning.
"Over the last twenty years, automated planning systems have demonstrated real clinical value — improving dosimetric quality, consistency and efficiency across multiple studies. But scaled adoption has remained elusive. The core challenge is that each plan must navigate complex, competing constraints that are specific to the individual patient, and there has been no robust way to consistently produce the optimal solution and confirm it meets the treating physician's clinical intent," said Tim Fox, Chief Product Officer at Lumonus.
"Our strategic collaboration with MSK represents a decisive step forward. The next generation of planning automation requires a mathematically principled solver capable of consistently delivering the optimal plan, working in concert with intelligent review tools that capture the nuanced clinical judgement of physicians in real-world practice. Together with MSK, we are building the infrastructure to move automation from promising results to scaled, routine deployment."
MSK's ECHO optimization engine uses constraint-based mathematical methods to compute radiation therapy treatment plans from first principles. Developed over nearly a decade of clinical use and supported by an extensive body of peer-reviewed research, ECHO represents one of the most rigorously validated approaches to automated treatment planning in radiation oncology
"Our goal in developing ECHO has always been to improve the quality, consistency, and efficiency of radiation therapy treatment planning," said Masoud Zarepisheh, PhD, Associate Attending and lead developer of ECHO at MSK. "Our collaboration with Lumonus creates an important opportunity to combine clinically validated optimization methods with modern workflow tools and help expand the adoption of automated treatment planning in radiation oncology."
About Lumonus
Lumonus is a healthcare technology company building Lumonus AI for radiation oncology. Built in partnership with leading cancer centers, the Lumonus AI platform is transforming cancer care through AI-native clinical workflows. The platform automates and orchestrates critical oncology tasks to improve quality, accelerate delivery and reduce administrative burden. Lumonus operates across the United States, Australia and Europe.
SYDNEY and NEW YORK, April 8, 2026 /PRNewswire/ -- Lumonus, the company behind Lumonus AI, a platform for radiation oncology clinical workflow and automated treatment planning, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK), one of the world's premier cancer centers and a leader in radiation therapy treatment planning research.
Through this relationship, Lumonus will license and co-develop MSK's ECHO mathematical optimization engine into the Lumonus platform and will invest in joint research focused on advancing automated radiation therapy treatment planning.
"Over the last twenty years, automated planning systems have demonstrated real clinical value — improving dosimetric quality, consistency and efficiency across multiple studies. But scaled adoption has remained elusive. The core challenge is that each plan must navigate complex, competing constraints that are specific to the individual patient, and there has been no robust way to consistently produce the optimal solution and confirm it meets the treating physician's clinical intent," said Tim Fox, Chief Product Officer at Lumonus.
"Our strategic collaboration with MSK represents a decisive step forward. The next generation of planning automation requires a mathematically principled solver capable of consistently delivering the optimal plan, working in concert with intelligent review tools that capture the nuanced clinical judgement of physicians in real-world practice. Together with MSK, we are building the infrastructure to move automation from promising results to scaled, routine deployment."
MSK's ECHO optimization engine uses constraint-based mathematical methods to compute radiation therapy treatment plans from first principles. Developed over nearly a decade of clinical use and supported by an extensive body of peer-reviewed research, ECHO represents one of the most rigorously validated approaches to automated treatment planning in radiation oncology
"Our goal in developing ECHO has always been to improve the quality, consistency, and efficiency of radiation therapy treatment planning," said Masoud Zarepisheh, PhD, Associate Attending and lead developer of ECHO at MSK. "Our collaboration with Lumonus creates an important opportunity to combine clinically validated optimization methods with modern workflow tools and help expand the adoption of automated treatment planning in radiation oncology."
About Lumonus
Lumonus is a healthcare technology company building Lumonus AI for radiation oncology. Built in partnership with leading cancer centers, the Lumonus AI platform is transforming cancer care through AI-native clinical workflows. The platform automates and orchestrates critical oncology tasks to improve quality, accelerate delivery and reduce administrative burden. Lumonus operates across the United States, Australia and Europe.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Lumonus launches strategic collaboration with leading global cancer center to advance radiation therapy treatment planning
SHANGHAI, April 8, 2026 /PRNewswire/ -- Following the commissioning of its 136,000-square-meter Smart Energy Center, Sigenergy has officially launched its inaugural utility-scale PV inverter. By integrating high-density hardware with millisecond-level control algorithms and AI-driven analytics, the solution addresses the industry's shift toward simplified system architectures and granular management for large-scale projects.
 
Sigenergy's utility solution leverages Silicon Carbide (SiC) MOSFETs to optimize thermal management and power conversion efficiency. Delivering a maximum output of 506kW, the unit enables a structural reduction in the number of inverters required per site, streamlining overall project scale.
- Cost Optimization: The platform supports a 1000V AC output, which lowers current levels and significantly reduces cabling expenses compared to traditional 800V systems. For 9.2MW block configurations, this design slashes BOS and installation costs by over 10% while simplifying field execution.
- Maximum Energy Harvest: While traditional high-power solutions often force a single MPPT to manage over 600 panels , Sigenergy's 18 MPPT Design ensures each channel manages only approximately 60 panels (two strings per MPPT). This granular control minimizes mismatch losses from shading or varying orientations, increasing annual energy yield by 1.5% to 2%.
Safety is the cornerstone of the Sigenergy platform, which utilizes a comprehensive protection suite to safeguard every critical electrical node.
- Comprehensive Safeguards: The system features utility-grade AFCI technology with an industry-leading 500m detection distance for rapid arc-fault and fire risk identification. Enhanced safety features also include on-board terminal temperature monitoring, reverse polarity protection, and Type I+II DC-side lightning protection to ensure maximum plant uptime and prevent reverse current damage.
- Industrial-Grade Durability & Thermal Mastery: To ensure 25-year operational reliability, the inverter features an IP66 rating and C5-H anti-corrosion coating for long-term stability in harsh coastal or industrial environments. Internal thermal management is driven by directed airflow to eliminate interference, paired with zigzag heat exchange technology to maintain peak performance under high-load conditions.
Sigenergy transforms maintenance from a reactive task to a prescriptive strategy through the integration of intelligent hardware and software.
- Precision Diagnostics: By refining control to just two strings per MPPT, the system isolates faults instantly, making troubleshooting 15 times faster than traditional systems where one MPPT manages dozens of strings.
- Millisecond-Level Intelligence: The proprietary MPPT algorithm utilizes multi-factor prediction to adjust at the millisecond level, ensuring the system remains locked onto the highest possible output during rapid weather fluctuations.
- Rapid Scanning: During partial shading events, the multi-peak scanning identifies the true global maximum in just 10 seconds—up to 6 times faster than the 40–60 seconds required by conventional solutions.
Embracing a Life Cycle Assessment (LCA) philosophy, Sigenergy optimizes value throughout the project's lifespan. High power density reduces raw material consumption per kilowatt during manufacturing. In the operational phase, precision MPPT management and intelligent O&M reduce both the carbon footprint and the resource demands of onsite services. By focusing on lowering LCOE through precise engineering, Sigenergy provides the global market with a robust foundation for the clean energy transition.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Sigenergy Enters Utility-Scale Market with 506kW Inverter, Delivering Optimized LCOE and Lifecycle Value
